Rheumatoid Arthritis — Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)
Citation(s)
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel-Group, 12-Week Study to Assess the Clinically Effective Dose Range of Etoricoxib and to Assess Its Safety and Tolerability in Patients With Rheumatoid Arthritis